We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

140 hedge funds and large institutions have $1.13B invested in Immunogen Inc in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $3.78M

70% more capital invested

Capital invested by funds: $665M → $1.13B (+$467M)

2% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 44

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

1% less funds holding

Funds holding: 141 → 140 (-1)

Holders
140
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
3.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
45
Reduced
44
Closed
23
Calls
$6.99M
Puts
$3.78M
Net Calls
+$3.2M
Net Calls Change
-$1.59M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$33.3M
2
Invesco
Invesco
Georgia
+$18.1M
3
BBA
Baker Bros. Advisors
New York
+$14.5M
4
O
OrbiMed
New York
+$11.3M
5
Franklin Resources
Franklin Resources
California
+$9.6M

Top Sellers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
-$25.4M
2
State Street
State Street
Massachusetts
-$10.6M
3
PCM
Penn Capital Management
Pennsylvania
-$3.33M
4
Barclays
Barclays
United Kingdom
-$3.19M
5
ARTA
A.R.T. Advisors
New York
-$3.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
ClearBridge Investments
1
ClearBridge Investments
New York
$211M +$2.24M +204,159 +1%
Primecap Management
2
Primecap Management
California
$185M +$2.84M +258,333 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$129M -$1.42M -129,586 -1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$82.3M +$1.6M +145,466 +3%
Millennium Management
5
Millennium Management
New York
$57.1M +$33.3M +3,029,108 +322%
State Street
6
State Street
Massachusetts
$47M -$10.6M -960,879 -23%
BFA
7
BlackRock Fund Advisors
California
$45.7M -$1.09M -99,241 -3%
BBA
8
Baker Bros. Advisors
New York
$33.4M +$14.5M +1,320,928 +132%
BIT
9
BlackRock Institutional Trust
California
$33M -$1.55M -141,339 -6%
Invesco
10
Invesco
Georgia
$23.7M +$18.1M +1,650,728 New
Norges Bank
11
Norges Bank
Norway
$23.6M – – –
Wells Fargo
12
Wells Fargo
California
$21.5M +$1.06M +96,880 +7%
PA
13
Pinnacle Associates
New York
$18.1M -$113K -10,320 -0.8%
Morgan Stanley
14
Morgan Stanley
New York
$15.8M +$1.73M +157,564 +17%
O
15
OrbiMed
New York
$14.8M +$11.3M +1,030,000 New
Northern Trust
16
Northern Trust
Illinois
$14.3M +$239K +21,729 +2%
MAA
17
Managed Account Advisors
New Jersey
$12.7M +$452K +41,125 +5%
Franklin Resources
18
Franklin Resources
California
$12.6M +$9.6M +874,050 New
BIM
19
Bogle Investment Management
Massachusetts
$12.2M +$9.35M +851,538 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$8.22M +$239K +21,781 +4%
RJA
21
Raymond James & Associates
Florida
$8.1M +$554K +50,444 +10%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$7.78M +$112K +10,188 +2%
Deutsche Bank
23
Deutsche Bank
Germany
$6.8M -$456K -41,527 -8%
Macquarie Group
24
Macquarie Group
Australia
$6.18M – – –
GIM
25
Granahan Investment Management
Massachusetts
$6.03M – – –
1
2 3 4 5

IMGN Hedge Fund Activity: Q2 2015 in Review

140 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2015, worth a combined $1.13B — up 70% from $665M a quarter earlier.

Fund positioning in IMGN was balanced in Q2 2015: 23 funds opened new positions, 23 closed out, 45 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $33.3M. The largest seller was BB Biotech, exiting entirely with an estimated $25.4M sold.

  • 140 institutional investors held Immunogen Inc (IMGN) as of Q2 2015, down from 141 in Q1 2015.
  • Funds reported $1.13B of Immunogen Inc stock for Q2 2015, up 70% quarter-over-quarter.
  • 23 funds opened new Immunogen Inc positions in Q2 2015 and 23 closed out, a net change of 0 holders.
  • The largest Immunogen Inc buyer in Q2 2015 was Millennium Management, an estimated $33.3M added.
  • The largest Immunogen Inc seller in Q2 2015 was BB Biotech, an estimated $25.4M sold.

Based on aggregated 13F filings for Q2 2015.